ESR1 and breast carcinoma: In terms of effect-modifying factors, similar to the meta-analysis conducted in 2021 (57), we conducted separate analyses to assess the effects of LAN exposure on breast cancer risk based on estrogen receptor status, types of study, and types of LAN exposure.